MSD Animal Health's equine division has launched a new series of materials to support its Keeping Britain's Horses Healthy Campaign.
For veterinary practices, there's a Vet Reception Pack designed to help receptionists educate owners why they should vaccinate and the benefits of preventive healthcare.
For yards, there are posters giving guidance and advice on prevention of Infectious Respiratory Disease and the steps which should be taken to control a potential outbreak. They can be tailor made for an individual yard.
Peter Young, MSD Animal Health Equine Business Manager said: "Our first wave of support materials focused very much on equine vets and owners - helping raise awareness of the importance of preventive healthcare and driving owners towards vets for advice. This phase of materials helps support yard owners and receptionists, aiming to fill some of those communications gaps where advice and guidelines on individual horse's vaccination requirements and yard protocols can play a vital role in preventing the spread of disease and controlling outbreaks."
Keeping Britain's Horses Healthy is a national campaign to educate horse owners on endemic infectious disease, vaccination, herd immunity and the importance of preventative healthcare. It includes a range of educational materials for veterinary surgeries and direct to owners. The campaign is supported by a national PR, advertising and social media programme, together with a dedicated website www.healthyhorses.co.uk. The website, aimed at driving owners back to their veterinary practices, includes a vet finder, exclusively for equine practices, and healthcare information.
For full details of the launch programme, talk to your account manager, call 01908 685685 or visit www.healthyhorses.co.uk.
Recent graduate, Sophie Gumble, from Head & Head Vets in Helston, Cornwall, has won a week for two in a luxury cottage in Cornwall.
Sophie won the prize after entering a draw run by Vetlife at the Veterinary Defence Society recent graduate meetings and the SPVS Lancaster Final Year Students’ Seminar last year.
The competition is run annually to raise awareness amongst younger members of the profession about the support that Vetlife provides through its support services: Vetlife Health Support, Vetlife Helpline and Vetlife Financial Support.
The prize, which was generously donated by former Vetlife Director Nicky Paull, will be offered again at the VDS reunions in 2016.
Sophie said: "I am a 2014 Liverpool graduate from Herefordshire, who entered the competition at the VDS reunion. The weekend was very useful and a great opportunity to catch up with friends and revive crazy dance moves!
"It has been a big move down to Cornwall. The busy life of a new vet, coupled with many weekends racing up the M5 to help with the family farm, has meant I am yet to really get the chance to enjoy and explore what the county of pasties and Poldark has to offer! I am excited to now have the chance to explore new parts of this wonderful county!"
It is hoped the findings, which were unveiled at the House of Commons yesterday, will enable the welfare priorities of the UK’s 800,000 horses to be addressed.
This is the first time welfare organisations, breeders, the equine industry and the veterinary profession have come together to agree on a strategy to best improve the welfare of horses in the UK.
The equine welfare study found the welfare needs of many horses are not currently being met and the report has highlighted four welfare priorities.
Dr Siobhan Mullan, Research Fellow in Animal Welfare Science, Ethics and Law at the University of Bristol and one of the report’s authors, said: "Bringing together the views of people associated with horses in England and Wales has provided an overview of horse welfare, from the day-to-day concerns of equine caregivers to identifying four priority challenges to equine welfare.
"This research has also identified how equine welfare can be improved, by addressing both the priority challenges, and a wider set of industry and horse-based needs."
Roly Owers, World Horse Welfare Chief Executive, added: "This research report provides a vital insight to the UK’s equine sector, mapping out the welfare landscape from a wide range of sector experts and stakeholders.
"In order for World Horse Welfare and others to most effectively address the welfare challenges facing UK equines, we need to better understand today’s welfare priorities and this research will provide a valuable guide to help in driving the focus of our educational initiatives and resources over the next few years.”
The priority welfare challenges and solutions outlined in the report are:
Unresolved stress/pain behaviourProblems associated with unresolved stress/pain behaviour affect large numbers of horses, often for long durations with variable severity of suffering caused to individual horses.
More academic research is needed to fully understand the links between behaviour, stress and pain, and objective measures of stress and pain in horses should be developed. Vets, riding instructors, the Pony Club, riding clubs and the equine press have a role in educating horse caregivers about signs of stress and pain and the appropriate responses. Academics and experts also have a role in tackling this issue through evaluating the effectiveness of intervention programmes.
Inappropriate nutritionOverfeeding and obesity are the main welfare problems associated with nutrition and affect large numbers of horses, often for a long time with varying severity of suffering.
Vets have a key role in tackling the problems associated with inappropriate nutrition. A consistent approach by all vets is needed, to prevent horse owners choosing vets that don’t challenge owners about their horses’ nutrition. Feed companies can also play an important role in tackling this issue, although many feed companies already offer appropriate nutrition for a range of horses and exercise situations. Better owner education, based on existing good research, would ensure the right nutritional choices are made for individual horses.
Inappropriate stabling /turnoutWelfare of horses is compromised when the amount of time spent at pasture/stabled does not meet their individual needs, when they are kept in social isolation or when they are exposed to unsuitable grazing conditions. Welfare problems associated with incorrect stabling/turnout affect large numbers of horses for a long time with variable levels of suffering.
Although all horse owners make choices relating to the amount and type of stabling and turnout experienced by their horses, livery yard owners could play a role in addressing this issue. For example, by encouraging different approaches to management, including group housing and the use of all-weather turnout facilities. Strengthening legislation is another possible way for improvement but a ‘one size fits all’ approach would be inappropriate. For example, for some horses, turn out to pasture may not always be suitable.
Delayed deathHorses may be kept alive inappropriately resulting in firstly, prolonging welfare problems, such as continued suffering of a horse in pain. This affects relatively large numbers of horses, for short periods of time with the severity of suffering often being severe. Secondly, an increased risk of suffering, for example where horses are unwanted by their owners, become low value and subsequently aren’t cared for well.
One way for improvement could be by putting pressure on the EU to make changes to the passport regulations. In particular, legislation changes that would enable horses who had received medications, including Phenylbutazone, to be slaughtered to enter the human food chain after a six month withdrawal period. In addition, challenging negative attitudes of horse owners towards timely euthanasia is important.
The research, undertaken over a four year period, was to understand the welfare status of horses in England and Wales, identify priority welfare issues and explore horse owner and industry experts’ perceptions of these issues.
Stakeholders from across the equine industry contributed to the research: from vets to farriers and welfare charities to governing body representatives, participants represented a wide-reaching cross section of horse care roles and responsibilities.
Matt, who contracted Lyme disease early last year, has been out giving interviews about how he was bitten by a tick, his experience with Lyme disease and why he is supporting the Big Tick Project. He said: "It was a really scary time for me and my family, and I was shocked to find out that a tick bite in Chiswick – such a tiny creature – caused me to end up needing heart surgery. Even though I am free from Lyme disease now it really has impacted me. I still have to take daily medication and I now adjust my lifestyle in a number of ways."
Amanda Melvin, Marketing Manager at MSD Animal Health said: "This recent campaign is part of a series of high profile media campaigns that we’ve organised to help pet owners understand the risks posed by ticks and the importance of seeking advice from vets. Vet are central to this campagn.
"During our attendance this summer at DogFest and Countryfile Live we asked pet owners about their awareness of the risks. While this was very rough data the message that came back consistently was that many pet owners didn’t realise that not all flea treatments could also provide protection against ticks.
"We are therefore urging them to talk to their vet and vet nurses to better understand the treatments they are paying for. The conversation is important as the risks can be high."
For further information, visit: www.bigtickproject.co.uk
The event is held every four years and hosted alternately by BEVA and the American Association of Equine Practitioners (AAEP).
It offers the opportunity for equine vets to absorb and digest the latest knowledge, clinical practice and scientific advances in the treatment and prevention of colic, from the world’s leading international equine gastroenterology experts.
Held over 2.5 days, the symposium comprises numerous 12-minute oral presentations on a range of topics including surgical techniques, treatment, parasitology, gastric ulceration, endotoxemia, pharmacology of intestinal motility, colic complications, epidemiology, physiology of digestion, the intestinal microbiome and metabolomics.
Each session will be followed by three minutes for questions and discussion.
Poster sessions on the first two days will cover ground beyond the oral presentations and delegates will be able to review and discuss the work with presenters.
There will also be opportunities to network with other equine vets, researchers and professionals.
Clinicians and scientists have until 1 February 2024 to submit abstracts of recent work that they wish to present at this meeting.
The scientific committee will consider abstracts on all aspects of equine gastroenterology, including basic science research and reports of clinical cases or novel approaches to treatment.
The abstract submission form is here: https://form.jotform.com/230473925626359
Tickets cost £475 (with a concessionary rate of £235 for post graduate students and interns) and includes a drinks reception on both 10th & 11th, an evening buffet and Ceilidh on 11th and lunch on 11th & 12th.
Further information and booking details can be found here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1740
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
A special interest group has been established for vets, veterinary nurses and chartered physiotherapists interested in the rehabilitation of diseased and injured animals. 'Physiovet UK' aims to provide practical training in the field of veterinary rehabilitation and pain management.
The group's inaugural CPD meeting takes place on Wednesday 20th May this year in Cardiff and will be led by specialist in small animal surgery (orthopedics) Steve Butterworth and veterinary rehabilitation specialist Lowri Davies. Sponsored by Hill's Pet Nutrition and Merial Animal Health, the meeting will cost £80 for members or £100 for non-members (ex VAT) for the day long event. Membership of the group costs £50.
Lowri Davies, a founder member of Physiovet said: "At this first meeting, the focus is on helping to develop a protocol for diagnosis and management strategies for conditions of the hock, shoulder and lumbosacral cases. Practitioners will recognise that these are commonly occurring conditions that are often managed conservatively but treatment need not stop with a prescription of 'rest'. We will be describing a range of active interventions that build strength, flexibility and general fitness appropriate to lame animals to help restore function and mobility."
For a downloadable registration form for the event, to join as a member or for further information about the group visit http://www.physiovet.co.uk/. Places at the meeting can also be booked by calling 01626 867614 or by contacting kathrin@linhayvet.co.uk.
For the randomised controlled trial, 528 dairy heifers were monitored for 34 months to investigate the effects of routine treatment with a NSAID at calving and during treatment for lameness, on the future probability of lameness and culling.
The cows were exposed to normal farm conditions and were split into four groups:
During the study, the probability of lameness was assessed by a lameness outcome score collected every 14 days.
Data on culling was also extracted from farm records.
438 animals were included in the final analysis which revealed that treating a cohort of cows following the group three protocol led to an absolute reduction in lameness of approximately 10% and severe lameness of 3%, compared with animals treated in accordance with conventional best practice (group one).
James Wilson BSc(Hons) PhD, foot health consultant and lead researcher on the trial, said: “It appears that through giving heifers a NSAID at critical time points, we have imparted a substantial, long-lasting benefit to them.
"When freshly calved heifers enter the herd for the first time, we understand that they are (typically) naïve to lameness and have good hoof health.
"By utilising NSAIDs strategically, we believe that we have preserved the functionality of the foot, thereby reducing the risk of lameness.
"This is a highly efficacious, cost-effective means of managing lameness on farm.”
Herd Health Consultancy says that in dairy cows, it is advisable to consider using a zero milk-withhold NSAID which is fully licensed to treat lameness in cattle to avoid any need to discard milk, however no NSAID is currently licensed in the UK to treat the pain associated with calving, so careful advice should be given to farmers based on the farm type and production methods.
https://doi.org/10.3168/jds.2021-21329
Reference
Genitrix has launched a scheme to help vet practices generate revenue through increasing sales of its canine mobility product, C2Collaplex. The scheme offers a money-back guarantee if clients and practices don’t see clear benefits from using C2Collaplex on dogs with mobility problems within a month.
In order to validate the scheme, clients are asked to complete a simple mobility score sheet and return it to the practice one month from the date of their original consultation. If both vet and client agree that C2Collaplex has made no difference, the practice will refund the client and Genitrix will forward on a replacement pack of C2Collaplex.
C2Collaplex, designed to promote the continuation of normal joint function in ageing and less mobile dogs, contains a range of nutritional substances, including Glucosamine HCl, Chronodroitin Sulphate, Vitamin C and Manganese, which help to support the musculo-skeletal system.
In addition, it contains purified Type II collagen which is the major protein of the cartilage in the joints. C2Collaplex is the only veterinary product to provide this protein in a purified form. According to Genitrix, it works by helping to switch off adverse processes and keeps cartilage normal.
In a retrospective study of 100 dogs presenting to practice with mobility problems, C2Collaplex was given as the only supportive agent and over 80% of veterinary surgeons and owners perceived a benefit from its use.
Commenting on the launch of ‘C2Collaplex Money Back Guarantee Scheme,’ Rob Watkins, Marketing Director of Genitrix, said: “The C2Collaplex Money Back Guarantee Scheme offers a win/win. It gives pet owners a well-priced, next generation product, which will help their dog. For the practice, it helps to build a strong revenue stream, with the guarantee of a refund if it fails to help an individual patient.”
For further information on participating, practices should contact Genitrix on 01403 786345.
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
Dechra Veterinary Products is offering CPD sessions as podcasts for the first time, as part of a new series of presentations on canine hyperadrenocorticism.
The Cushing's Challenge series, which will also be available as webcasts with supporting notes, is designed to challenge vets to update their knowledge on the syndrome.
There will be six presentations released on the company's online learning resource, The Dechra Academy, starting this month.
Dechra Veterinary Products Brand Manager, Craig Sankey said: "Although Cushing's is a common canine endocrinopathy, it can be challenging to diagnose and can mimic non-adrenal disorders. Test results can also sometimes be inconclusive which is why we've developed this series of CPD sessions to support veterinary professionals who want to update their knowledge.
"The Cushing's Challenge series will be the first time Dechra has used podcasts to deliver CPD, which can be downloaded and listened to on any MP3 player. They can also be viewed on a PC or tablet as a webcast with each of the presentations varying in length, from around 12 to 25 minutes long. By offering the presentations in both of these formats, we are able to offer flexible support to help busy veterinary professionals with CPD.
"The first episodes will focus on pathophysiology, clinical signs and routine lab tests with successive presentations released in the coming weeks. The next two in the series will cover diagnostic tests and then differentiation tests."
CPD certificates will be available at the end of the series via email.
The free-of-charge CPD is accompanied by client support materials for practices as part of Dechra's new Vetoryl campaign.
The Cushing's Challenge CPD is available at www.dechra.co.uk/academy,
Nominees for the RCVS Council and its Veterinary Nurses Council have been announced, with 13 candidates for the former and four for the latter.
The nominations closed on 31 January, and the following are standing:
RCVS Council
* denotes current RCVS Council member
VN Council
* denotes current VN Council member
MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.
Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy farmers - is licensed for use in young, pregnant and lactating animals, with a 72-hour milk withhold period where milk is produced for human consumption.
MSD Animal Health veterinary advisor Matt Haslam said: "The latest independent data1 confirms that fluke is on the increase in UK cattle and sheep. The fluke problem is longstanding, but is being exacerbated by recent wet summer and autumn periods that have created ideal conditions for this parasite to proliferate and infect grazing livestock.
"Chronic liver fluke causes serious economic losses for livestock farmers. In dairy herds, for example, there will be a negative impact on fertility and milk production where cows are affected.
"It is important that farmers have access to the best treatment options given the size of the threat and the scale of potential losses. Zanil is used widely and effectively in Ireland in the control of fluke problems, and there is no known resistance to the active ingredient oxyclozanide. With its re-introduction into the country, we believe Zanil is unique as a flukicide-only treatment that is licensed for use in lactation and in the dry period for the treatment of adult fluke in dairy cows."
Zanil is an oral drench with POM-VPS authorisation, available from both animal health suppliers and veterinary practices. Dosage rate is 3ml per 10kg bodyweight in cattle, up to a maximum of 105ml, and 4.5ml per 10kg bodyweight in sheep, up to a maximum of 20ml.
See DEFRA emerging threats reports in sheep and cattle, Q1 2013: www.defra.gov.uk/ahvla-en/files/pub-survrep-sr0113.pdf
The investment is being made to increase the speed at which concerns are either closed or referred, ensure that the process meets its service standards and reduce stress for the public and profession.
The decision to increase investment in the process was made by the College’s Operational Board in response to a steady increase in the number of concerns being investigated. The College forecasts that it will receive in excess of 1,000 concerns raised about the professional conduct of veterinary surgeons and veterinary nurses this year.
The RCVS developed a simplified, three-stage concerns process in 2014 which included the introduction of targets for cases to be either closed or referred at each stage. In order to ensure that these targets can be met, the College will now be hiring five paralegals to assist the existing five case managers.
Eleanor Ferguson, Acting Registrar, said: "Currently we are only closing or referring just over half of concerns we receive at stage 1 (case examiner stage) within our four month target. In order for the system to run more smoothly we will be investing in extra staff to help clear the backlog and ensure that these targets are met going forward.
"Similarly, in order to deal with the increase in the number of cases being referred to Preliminary Investigation Committee (stage 2), we will be increasing the frequency of these committee meetings from one to two per month.
"It is important to add that this investment is not just about dealing with concerns more quickly but is also about quality of service and having more staff on hand will ensure that this quality is maintained in terms of how we communicate with complainants and members of the profession. Speeding up the process will reduce the stress and anxiety felt by all involved."
More details about the College’s concerns investigation process and its different stages can be found at www.rcvs.org.uk/concerns
The 15 minute video (see below) is hosted by Chris Dixon, veterinary ophthalmologist and director at Veterinary Vision Ophthalmic Referrals, who discusses things to consider when examining a patient with an ocular disorder. He offers practical advice on how to perform an ocular examination, including tips on how to use an ophthalmoscope effectively, examining the ocular structures including the front eye, distant direct examination, indirect examination and close direct examination.
Chris said: "This series of videos aims to help vets learn how to perform the fundamental techniques of ophthalmic examination, hopefully enabling them to spot potentially degenerative conditions earlier. The second video in particular delves into practical tips that vets can use within practice. The videos have been created in partnership with Bayer as part of their ongoing commitment to training, and aim to help ensure that chronic conditions, such as keratoconjunctivitis sicca (KCS), or dry eye, are diagnosed and treated early."
The veterinary practice waiting room display materials are designed to help practices educate dog owners on the signs and management of Dry Eye in the hope that the condition may be diagnosed and treated earlier and to emphasise the importance of ongoing treatment and management.
Hannah Watts, Group Product Manager at Bayer said: "It is important that dog owners with a predisposed breed are aware that their pet may be at risk of developing Dry Eye and are aware of the symptoms. Annual testing in at risk breeds for Dry Eye is recommended to help reach an early diagnosis and optimise the chances of a successful treatment outcome."
The Dry Eye practice display materials are available to order via the Bayer Vet Centre www.vetcentre.bayer.co.uk. Alternatively, ask your Bayer rep for more details.
fVtqNMj35c8
Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
According to the Spring 2022 Voice of the Profession survey, one in four cats (24%) seen in practices are not having all of their welfare needs met.
The issues identified by vets as the most pressing at their practice were:
Open to everyone in the profession, Congress '24 will include over 130 hours of CPD across 32 different modules covering topics such as advanced diabetes, dermatology, nursing clinics, EDI and more.
The programme format caters to a variety of learning styles, from lectures and panel discussions to interactive sessions and free CPD workshops.
There'll be over 120 exhibitors in three commercial exhibition, offering insights into some of the latest industry innovations, from pharmaceuticals to cutting-edge equipment.
Andy Green, Chair of the Congress Committee said: "We know it's a significant commitment for individuals to give up one to three days, plus travel time, to join us, and we don't just aim to educate; we want our attendees to enjoy the experience.
"Our aspiration is not just to meet their expectations but to exceed them.
"The veterinary profession faces challenges, but we have so much to celebrate, and what better place to come together with many like-minded individuals to remind yourself why you wanted to be in this profession in the first place."
Early bird registration is open until 31st January, and prices start at £93 +VAT for BSAVA members for a one-day pass.
www.bsavacongress.com
At the roundtable, Liz Barton MRCVS, Head of Communications at Vet.CT, spoke about the application of AI in clinical practice, including in preventative medicine, diagnostics, treatment and prognostics.
Liz highlighted how the use of AI tools in clinical practice for tasks such as pattern recognition had led to many unforeseen and unexpected benefits, for example by picking up things that humans may not.
Dr P-J Noble, Senior Lecturer in Small Animal Science at the University of Liverpool, explained how AI tools had proven useful in processing, assessing and annotating qualitative data gathered through the university's Small Animal Veterinary Surveillance Network (SAVSNET) once they were programmed to recognise certain patterns, saving lots of research time and costs.
Dr Chris Trace MRCVS, Head of Digital Learning at the University of Surrey, spoke about AI use in higher education and how it has already started to be used beneficially both as a teaching and learning aid, as well as for assessment and feedback.
In the afternoon session, groups of delegates were asked to discuss practical questions over AI use in the veterinary professions and how it might be regulated.
There were discussions on how to help vet and VN students make the most of AI in learning and assessment, responsible use of AI in clinical settings, the risks of not using AI, how veterinary professionals can work with animal owners and keepers to ensure the safe and productive use of AI, and whether AI-led devices should be regulated.
Lizzie said: “This was a really positive and exciting event that involved a heady mix of trepidation over the risks and implications of AI now and into the future, and optimism over the beneficial impact it could have for education, diagnosis, treatment and patient outcomes.
"The discussions have certainly given us at the College a lot of food for thought on how we can put in place guardrails and guidelines on the appropriate use of AI in the veterinary sector.
“This is an area of technology that is evolving so rapidly that it would not be effective for us to put in place specific guidance for the use of AI tools, but instead we will be looking at how we can regulate the use of AI in the round and ensure our principles are sufficiently future-proofed to keep up with the pace of change.
“Any regulation will start with first principles, such as transparency and honesty around the use of AI in veterinary practice, the minimisation of potential risks, and the continuing importance of professional accountability for decision-making, even where such decisions may have been heavily influenced by the use of AI tools and AI-generated data.”
The input gathered from the roundtable will now be considered by a range of RCVS committees over the coming months.
A full report of the event will be published this summer.
Guernsey-based vet, VetSurgeon member David Chamberlain has officially launched a revolutionary cat flap which synchronises with a cat's microchip to control access to the house. The Pet Porte Microchip Cat Flap is the first cat flap that works in conjunction with microchips and has already been winning awards.
Aside from allowing only the homeowner's cats into the house, the Pet Porte Microchip Cat Flap has a number of other interesting features. ‘Vet Mode' allows recognised cats in, but does NOT allow them out, useful when a trip to the vet is on the calendar. ‘Night Mode' uses an automatic daylight sensor to lock the door as ambient light levels drop, keeping cats inside and safe. An audible beep (which can be turned off) provides an alert when a programmed cat enters though the flap.
The Pet Porte Microchip Cat Flap recognises 15 digit UK/European FDX-B microchips. Owners of cats that have already beed chipped can check check compatibility with the Pet Porte's 'Chip Checker'.
The cat flap can recognise up to 32 microchipped cats, and programming it is very simple. When the unit is first installed, the owner holds down a green paw button for ten seconds and passes their cat under the porch for the microchip to be programmed into the system.
A review on Pet Porte's website caught my eye:"Just like to say how absolutely fabulous the cat flap is. I've slashed my cat food bill now I'm not feeding the entire street!" On top of that, as Pet Porte says, this system also encourages microchipping, an important part of responsible pet ownership.
The Pet Porte microchip cat flap is currently being marketed in the UK through veterinary practices and online from http://www.petporte.com/. For all sales enquiries call 01481 265 359, email sales@petporte.com or visit www.petporte.com.
Alternatively, 'Start a Conversation' directly with David by clicking the link on his VetSurgeon profile.
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
Zoetis Business Consulting has announced the launch of Profitsolver, a software tool designed to boost practice profits.
The software has already been rolled out in the US, where Zoetis says that it has delivered an average of £103,000 extra profit to veterinary practices within a year.
Profitsolver uses the practice's actual data - not benchmarks or accepted norms - to enable the practice to manage costs, set prices and gain return on investments. By using an activity-based costing model and using a variety of data such as practice costs, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profitsolver calculates the correct pricing to both cover costs and deliver a predetermined profit margin.
Zoetis says that Profitsolver helps practices to understand how the overall practice profit is being generated. For instance, for price sensitive procedures such as vaccination, the practice can match their prices with the competition, but maintain their profit margin by increasing the price for other clinical services.
Nick Steele, national consulting manager at Zoetis said: "Veterinary practices have no standard method for pricing their services and they are often unable to determine which services make money and which don't. This hampers the practice's ability to accurately value the business and, as a result, profit levels tend to be low for many practices. Profitsolver can turn this situation around and already has a very successful track record in the US."
Zoetis piloted the UK version of Profitsolver with John Goulding at St Georges Veterinary Group. He said: "By and large the veterinary profession still relies on the mark-up of medicines where profits are concerned. Even practices that have made a concerted effort to move away from this type of pricing structure are still making their money from the sale of medicines rather than from vets' fees. For years I have wanted to know exactly how to price our services and this new Profitsolver software does just that.
"Most costs have an element of staff time, an element of fixed assets or equipment and an element of disposable items. Profitsolver takes all of these into account, adds the predetermined profit margin and produces an accurate pricing structure for each procedure undertaken within the practice.
"It's important to take the time at the start to put accurate data in from the practice's latest set of accounts and the Zoetis business consultant will guide practices through this to make the initial set up as easy as possible. For instance, for major pieces of equipment such as X-ray machines, you have to work out how many times a year you are likely to use them.
"By using Profitsolver, we worked out that if we do exactly the same amount of work as last year we can increase our bottom line by at least £200,000 for our 18 vet practice. Since last November, when we installed Profitsolver, we have completely changed our pricing structure moving away from focusing on medicines and the size of the animal to rethink how we charge our clinical care.
"An unexpected benefit is that Profitsolver has made me much more confident about the prices we charge to clients as it is all broken down, so we can see exactly how the invoice is made up. I would be at a loss without it now."
For more information about Profitsolver, contact your Zoetis account manager.
A further 1,200 practices outside Europe have also embraced the scheme, which ISFM has been running with support from Purina.
There are signs that this number is set to grow. In a survey conducted by ISFM and Onswitch at BSAVA Congress this year, more than 80% of veterinary surgeons and nurses were aware of the Cat Friendly Clinic programme and over 20% said that they were working towards accreditation.
The charity says that in addition to this growth in the number of accredited practices, there has been a more general move in the profession towards positive action for the welfare of cats in daily practice, often championed by veterinary nurses.
It is often the nurses, says the charity, who have implemented the changes required to create a less stressful environment for cats. It is the nurses too who have reported changes in the behaviour of cats within the clinic. With less stress and aggression in the clinic, cats are easier to handle and owners are much happier with the relationship between them, the cat and the clinic.
Andy Sparkes, ISFM Director said: "It is so exciting to see the changes which are happening – not only are we improving our veterinary care, but we are making the whole veterinary experience better for cats and their owners.
"Clinics also notice a difference in practice revenue, as well as having very happy clients. Clients notice the difference in their cats’ behaviour and clinics become known for being cat friendly. Previously it has been difficult to market the clinic to cat clients who need a very different message to dog clients.
"The benefits of having everyone in the practice on the same cat friendly page are many: nurses' lives are made easier by having calmer cats to deal with, vets can carry out procedures more easily because cats are less aggressive, and owners receive the same cat-friendly message about cat care no matter who they speak to within the clinic. Most importantly, the patients themselves are less stressed, less fearful and more likely to have a successful diagnosis and treatment. This leads to more satisfaction, more success in treating cats, and to much better cat welfare.'
According to the charity, veterinary practice architects and designers are also taking on the idea and most new premises are now being built with separate waiting areas for cats and separate feline hospital wards.
Matthew Rees of Technic, the hospital cage manufacturer, says he has noticed "a significant and quite dramatic increase in both the awareness and desire to achieve ISFM Gold Cat Friendly Clinic accreditation".
The company has designed a new range of ISFM gold standard cat pens. Matthew said: "The CFC scheme has also made a huge difference to us as manufacturers – with International Cat Care’s assistance and straightforward advice, we have now started to understand cats and in fact 'think feline’! Our products are without doubt far better due to this and ultimately it is the cats of the world that will benefit."
Inga Feller Devaud, from Purina said: "The Cat Friendly Clinic programme is changing veterinary practice for good. Our aim is that cats will no longer be treated as small dogs and that the veterinary experience for cats and their owners will be much less stressful, and barriers to visits will be removed, improving both preventive healthcare and speed of treatment for ill cats. Purina is delighted to be partnering with International Cat Care and ISFM at the forefront of these changes."
For more information on how to become a Cat Friendly Clinic, visit: www.catfriendlyclinic.org